[{"Assets_0_Q2_USD":60263000000.0,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.52,"CommonStockDividendsPerShareDeclared_2_Q2_USD":1.04,"CommonStockSharesOutstanding_0_Q2_shares":1306000000.0,"EarningsPerShareBasic_1_Q2_USD":2.35,"EarningsPerShareBasic_2_Q2_USD":4.42,"EarningsPerShareDiluted_1_Q2_USD":2.33,"EarningsPerShareDiluted_2_Q2_USD":4.38,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":6451000000.0,"NetIncomeLoss_1_Q2_USD":3073000000.0,"NetIncomeLoss_2_Q2_USD":5775000000.0,"StockholdersEquity_0_Q2_USD":22677000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":1317000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":1319000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1307000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1307000000.0,"Ticker":"GILD","CIK":"882095","name":"GILEAD SCIENCES INC","OfficialName":"Gilead Sciences Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"78838305412.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20170807"}]